{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Loading the data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "maude_fda_data = pd.read_excel('fda_device_data - Subset.xlsx')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>event_type</th>\n",
       "      <th>date_of_event</th>\n",
       "      <th>product_problems</th>\n",
       "      <th>complaint_txt</th>\n",
       "      <th>follow_up</th>\n",
       "      <th>manufacturer_narrative</th>\n",
       "      <th>device_generic_name</th>\n",
       "      <th>device_manufacturer_name</th>\n",
       "      <th>device_model_number</th>\n",
       "      <th>device_lot_number</th>\n",
       "      <th>device_report_product_code</th>\n",
       "      <th>expiration_date_of_device</th>\n",
       "      <th>date_returned_to_manufacturer</th>\n",
       "      <th>device_availability</th>\n",
       "      <th>device_operator</th>\n",
       "      <th>device_name</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Malfunction</td>\n",
       "      <td>20200418</td>\n",
       "      <td>['Battery Problem', 'Power Problem']</td>\n",
       "      <td>INFORMATION RECEIVED BY MEDTRONIC INDICATED TH...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT...</td>\n",
       "      <td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD S...</td>\n",
       "      <td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td>\n",
       "      <td>MMT-1715K</td>\n",
       "      <td>HG1B44Y</td>\n",
       "      <td>OZO</td>\n",
       "      <td>NaN</td>\n",
       "      <td>20200429.0</td>\n",
       "      <td>Device was returned to manufacturer</td>\n",
       "      <td>LAY USER/PATIENT</td>\n",
       "      <td>Automated Insulin Dosing , Threshold Suspend</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Malfunction</td>\n",
       "      <td>20200421</td>\n",
       "      <td>['Excess Flow or Over-Infusion', 'Battery Prob...</td>\n",
       "      <td>INFORMATION RECEIVED BY MEDTRONIC INDICATED TH...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEV...</td>\n",
       "      <td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVAS...</td>\n",
       "      <td>MEDTRONIC MINIMED</td>\n",
       "      <td>MMT-XXX</td>\n",
       "      <td>NaN</td>\n",
       "      <td>OYC</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>LAY USER/PATIENT</td>\n",
       "      <td>Pump, Infusion, Insulin, To Be Used With Invas...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Injury</td>\n",
       "      <td>20200407</td>\n",
       "      <td>['Failure to Charge', 'Battery Problem']</td>\n",
       "      <td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG ...</td>\n",
       "      <td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td>\n",
       "      <td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td>\n",
       "      <td>CD1357-40Q</td>\n",
       "      <td>4443992</td>\n",
       "      <td>LWS</td>\n",
       "      <td>20160131.0</td>\n",
       "      <td>20200422.0</td>\n",
       "      <td>Device was returned to manufacturer</td>\n",
       "      <td>HEALTH PROFESSIONAL</td>\n",
       "      <td>Implantable Cardioverter Defibrillator (Non-Crt)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Malfunction</td>\n",
       "      <td>20200402</td>\n",
       "      <td>['Battery Problem']</td>\n",
       "      <td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPL...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD...</td>\n",
       "      <td>CONTINUOUS GLUCOSE MONITOR</td>\n",
       "      <td>TANDEM DIABETES CARE</td>\n",
       "      <td>1000096</td>\n",
       "      <td>NaN</td>\n",
       "      <td>OYC</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>LAY USER/PATIENT</td>\n",
       "      <td>Pump, Infusion, Insulin, To Be Used With Invas...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Malfunction</td>\n",
       "      <td>20200414</td>\n",
       "      <td>['Battery Problem']</td>\n",
       "      <td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI O...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ...</td>\n",
       "      <td>ICD</td>\n",
       "      <td>BIOTRONIK SE &amp; CO. KG</td>\n",
       "      <td>383594</td>\n",
       "      <td>NaN</td>\n",
       "      <td>LWS</td>\n",
       "      <td>20150228.0</td>\n",
       "      <td>20210302.0</td>\n",
       "      <td>Device was returned to manufacturer</td>\n",
       "      <td>HEALTH PROFESSIONAL</td>\n",
       "      <td>Implantable Cardioverter Defibrillator (Non-Crt)</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    event_type  date_of_event  \\\n",
       "0  Malfunction       20200418   \n",
       "1  Malfunction       20200421   \n",
       "2       Injury       20200407   \n",
       "3  Malfunction       20200402   \n",
       "4  Malfunction       20200414   \n",
       "\n",
       "                                    product_problems  \\\n",
       "0               ['Battery Problem', 'Power Problem']   \n",
       "1  ['Excess Flow or Over-Infusion', 'Battery Prob...   \n",
       "2           ['Failure to Charge', 'Battery Problem']   \n",
       "3                                ['Battery Problem']   \n",
       "4                                ['Battery Problem']   \n",
       "\n",
       "                                       complaint_txt follow_up  \\\n",
       "0  INFORMATION RECEIVED BY MEDTRONIC INDICATED TH...       NaN   \n",
       "1  INFORMATION RECEIVED BY MEDTRONIC INDICATED TH...       NaN   \n",
       "2  FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ...       NaN   \n",
       "3  IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPL...       NaN   \n",
       "4  IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI O...       NaN   \n",
       "\n",
       "                              manufacturer_narrative  \\\n",
       "0  (B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT...   \n",
       "1  CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEV...   \n",
       "2  THE RESULTS/METHOD AND CONCLUSION CODES ALONG ...   \n",
       "3  NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD...   \n",
       "4  THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ...   \n",
       "\n",
       "                                 device_generic_name  \\\n",
       "0  ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD S...   \n",
       "1  PUMP, INFUSION, INSULIN, TO BE USED WITH INVAS...   \n",
       "2             IMPLANTABLE CARDIOVERTER DEFIBRILLATOR   \n",
       "3                         CONTINUOUS GLUCOSE MONITOR   \n",
       "4                                                ICD   \n",
       "\n",
       "                device_manufacturer_name device_model_number  \\\n",
       "0   MEDTRONIC PUERTO RICO OPERATIONS CO.           MMT-1715K   \n",
       "1                      MEDTRONIC MINIMED             MMT-XXX   \n",
       "2  ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)          CD1357-40Q   \n",
       "3                   TANDEM DIABETES CARE             1000096   \n",
       "4                  BIOTRONIK SE & CO. KG              383594   \n",
       "\n",
       "  device_lot_number device_report_product_code  expiration_date_of_device  \\\n",
       "0           HG1B44Y                        OZO                        NaN   \n",
       "1               NaN                        OYC                        NaN   \n",
       "2           4443992                        LWS                 20160131.0   \n",
       "3               NaN                        OYC                        NaN   \n",
       "4               NaN                        LWS                 20150228.0   \n",
       "\n",
       "   date_returned_to_manufacturer                  device_availability  \\\n",
       "0                     20200429.0  Device was returned to manufacturer   \n",
       "1                            NaN                                   No   \n",
       "2                     20200422.0  Device was returned to manufacturer   \n",
       "3                            NaN                                   No   \n",
       "4                     20210302.0  Device was returned to manufacturer   \n",
       "\n",
       "       device_operator                                        device_name  \n",
       "0     LAY USER/PATIENT       Automated Insulin Dosing , Threshold Suspend  \n",
       "1     LAY USER/PATIENT  Pump, Infusion, Insulin, To Be Used With Invas...  \n",
       "2  HEALTH PROFESSIONAL   Implantable Cardioverter Defibrillator (Non-Crt)  \n",
       "3     LAY USER/PATIENT  Pump, Infusion, Insulin, To Be Used With Invas...  \n",
       "4  HEALTH PROFESSIONAL   Implantable Cardioverter Defibrillator (Non-Crt)  "
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "maude_fda_data.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### CSV Knowledge Base - Does not work using Phi "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "from phi.knowledge.csv import CSVKnowledgeBase\n",
    "from phi.vectordb.chroma import ChromaDb"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "maude_knowledge_base = CSVKnowledgeBase(\n",
    "    path=\"fda_device_data - Subset.xlsx\",\n",
    "    vector_db=ChromaDb(collection=\"maude\"),\n",
    ")\n",
    "# Comment out after first run\n",
    "#maude_knowledge_base.load(recreate=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "CSVKnowledgeBase(reader=CSVReader(chunk=True, chunk_size=3000, separators=['\\n', '\\n\\n', '\\r', '\\r\\n', '\\n\\r', '\\t', ' ', '  '], chunking_strategy=<phi.document.chunking.fixed.FixedSizeChunking object at 0x0000028E0160C040>), vector_db=<phi.vectordb.chroma.chromadb.ChromaDb object at 0x0000028E0160C730>, num_documents=5, optimize_on=1000, driver='knowledge', chunking_strategy=<phi.document.chunking.fixed.FixedSizeChunking object at 0x0000028E0160C040>, path='fda_device_data - Subset.xlsx')"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "maude_knowledge_base"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #000080; text-decoration-color: #000080\">INFO    </span> Creating collection                                                                                       \n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[34mINFO    \u001b[0m Creating collection                                                                                       \n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #000080; text-decoration-color: #000080\">INFO    </span> Loading knowledge base                                                                                    \n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[34mINFO    \u001b[0m Loading knowledge base                                                                                    \n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "3474b42b34144c89a4f65fad86a27e4c",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from phi.agent import Agent\n",
    "\n",
    "agent = Agent(\n",
    "    knowledge=maude_knowledge_base,\n",
    "    search_knowledge=True,\n",
    ")\n",
    "agent.knowledge.load(recreate=False)\n",
    "\n",
    "agent.print_response(\"What are the potential hazards present from the knowledge base?\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### Response:  I couldn't find any specific information in the knowledge base regarding potential hazards. If you have more specific details or a certain context in mind, please let me know so I can assist you better! "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: openai in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (1.59.6)\n",
      "Requirement already satisfied: lancedb in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (0.17.0)\n",
      "Requirement already satisfied: tantivy in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (0.22.0)\n",
      "Requirement already satisfied: pypdf in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (5.1.0)\n",
      "Requirement already satisfied: sqlalchemy in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (2.0.37)\n",
      "Requirement already satisfied: anyio<5,>=3.5.0 in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (from openai) (4.8.0)\n",
      "Requirement already satisfied: distro<2,>=1.7.0 in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (from openai) (1.9.0)\n",
      "Requirement already satisfied: httpx<1,>=0.23.0 in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (from openai) (0.27.0)\n",
      "Requirement already satisfied: jiter<1,>=0.4.0 in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (from openai) (0.8.2)\n",
      "Requirement already satisfied: pydantic<3,>=1.9.0 in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (from openai) (2.10.5)\n",
      "Requirement already satisfied: sniffio in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (from openai) (1.3.1)\n",
      "Requirement already satisfied: tqdm>4 in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (from openai) (4.67.1)\n",
      "Requirement already satisfied: typing-extensions<5,>=4.11 in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (from openai) (4.12.2)\n",
      "Requirement already satisfied: deprecation in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (from lancedb) (2.1.0)\n",
      "Requirement already satisfied: pylance==0.20.0 in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (from lancedb) (0.20.0)\n",
      "Requirement already satisfied: packaging in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (from lancedb) (24.2)\n",
      "Requirement already satisfied: overrides>=0.7 in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (from lancedb) (7.7.0)\n",
      "Requirement already satisfied: pyarrow>=14 in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (from pylance==0.20.0->lancedb) (18.1.0)\n",
      "Requirement already satisfied: numpy>=1.22 in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (from pylance==0.20.0->lancedb) (1.26.4)\n",
      "Requirement already satisfied: greenlet!=0.4.17 in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (from sqlalchemy) (3.1.1)\n",
      "Requirement already satisfied: exceptiongroup>=1.0.2 in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (from anyio<5,>=3.5.0->openai) (1.2.2)\n",
      "Requirement already satisfied: idna>=2.8 in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (from anyio<5,>=3.5.0->openai) (3.10)\n",
      "Requirement already satisfied: certifi in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (from httpx<1,>=0.23.0->openai) (2024.12.14)\n",
      "Requirement already satisfied: httpcore==1.* in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (from httpx<1,>=0.23.0->openai) (1.0.7)\n",
      "Requirement already satisfied: h11<0.15,>=0.13 in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (from httpcore==1.*->httpx<1,>=0.23.0->openai) (0.14.0)\n",
      "Requirement already satisfied: annotated-types>=0.6.0 in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (from pydantic<3,>=1.9.0->openai) (0.7.0)\n",
      "Requirement already satisfied: pydantic-core==2.27.2 in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (from pydantic<3,>=1.9.0->openai) (2.27.2)\n",
      "Requirement already satisfied: colorama in h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages (from tqdm>4->openai) (0.4.6)\n"
     ]
    }
   ],
   "source": [
    "!pip install openai lancedb tantivy pypdf sqlalchemy"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #000080; text-decoration-color: #000080\">INFO    </span> Creating collection                                                                                       \n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[34mINFO    \u001b[0m Creating collection                                                                                       \n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #000080; text-decoration-color: #000080\">INFO    </span> Loading knowledge base                                                                                    \n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[34mINFO    \u001b[0m Loading knowledge base                                                                                    \n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "9afa947d112f4b45aa1c0906ff645cd6",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from phi.agent import Agent\n",
    "from phi.model.openai import OpenAIChat\n",
    "from phi.embedder.openai import OpenAIEmbedder\n",
    "from phi.knowledge.pdf import PDFUrlKnowledgeBase\n",
    "from phi.knowledge.csv import CSVKnowledgeBase\n",
    "from phi.vectordb.lancedb import LanceDb, SearchType\n",
    "\n",
    "# Create a knowledge base from a PDF\n",
    "knowledge_base = CSVKnowledgeBase(\n",
    "    path=\"H:\\Interview Preparation\\Coding\\GenAI\\Tryouts\\6-Maude DB Analysis\\fda_device_data - Subset.xlsx\",\n",
    "    # Use LanceDB as the vector database\n",
    "    vector_db=LanceDb(\n",
    "        table_name=\"maude\",\n",
    "        uri=\"tmp/lancedb\",\n",
    "        search_type=SearchType.vector,\n",
    "        embedder=OpenAIEmbedder(model=\"text-embedding-3-small\"),\n",
    "    ),\n",
    ")\n",
    "# Comment out after first run as the knowledge base is loaded\n",
    "knowledge_base.load(recreate=False)\n",
    "\n",
    "agent = Agent(\n",
    "    model=OpenAIChat(id=\"gpt-4o\"),\n",
    "    # Add the knowledge base to the agent\n",
    "    knowledge=knowledge_base,\n",
    "    show_tool_calls=True,\n",
    "    markdown=True,\n",
    ")\n",
    "agent.print_response(\"What are the potential problem present from the knowledge base?\", stream=True)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Langchain RAG- Implementation "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#!pip install unstructured openpyxl chardet iso-639"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "!pip uninstall iso-639\n",
    "#pip install iso-639\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: iso-639\n",
      "Version: 0.4.5\n",
      "Summary: Python library for ISO 639 standard\n",
      "Home-page: https://github.com/noumar/iso639\n",
      "Author: Mikael Karlsson\n",
      "Author-email: i8myshoes@gmail.com\n",
      "License: AGPLv3\n",
      "Location: h:\\interview preparation\\coding\\genai\\tryouts\\venv\\lib\\site-packages\n",
      "Requires: \n",
      "Required-by: \n"
     ]
    }
   ],
   "source": [
    "!pip show iso-639\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "False\n",
      "False\n"
     ]
    }
   ],
   "source": [
    "import iso639\n",
    "\n",
    "print(hasattr(iso639, \"Language\"))\n",
    "print(hasattr(iso639, \"LanguageNotFoundError\"))\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### Data Splitting from excel file "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_community.document_loaders import UnstructuredCSVLoader, UnstructuredExcelLoader\n",
    "from langchain.text_splitter import RecursiveCharacterTextSplitter, CharacterTextSplitter, RecursiveJsonSplitter"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "file_path = r\"H:\\Interview Preparation\\Coding\\GenAI\\Tryouts\\6-Maude DB Analysis\\fda_device_data - Subset.xlsx\"\n",
    "file_path_1 = r'H:\\Interview Preparation\\Coding\\GenAI\\Tryouts\\6-Maude DB Analysis\\fda_device_data.xlsx'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "ename": "AttributeError",
     "evalue": "module 'iso639' has no attribute 'LanguageNotFoundError'",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mAttributeError\u001b[0m                            Traceback (most recent call last)",
      "File \u001b[1;32mh:\\Interview Preparation\\Coding\\GenAI\\Tryouts\\venv\\lib\\site-packages\\unstructured\\partition\\common\\lang.py:367\u001b[0m, in \u001b[0;36m_get_iso639_language_object\u001b[1;34m(lang)\u001b[0m\n\u001b[0;32m    366\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m--> 367\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43miso639\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mLanguage\u001b[49m\u001b[38;5;241m.\u001b[39mmatch(lang\u001b[38;5;241m.\u001b[39mlower())  \u001b[38;5;66;03m# pyright: ignore[reportUnknownMemberType]\u001b[39;00m\n\u001b[0;32m    368\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m iso639\u001b[38;5;241m.\u001b[39mLanguageNotFoundError:\n",
      "\u001b[1;31mAttributeError\u001b[0m: module 'iso639' has no attribute 'Language'",
      "\nDuring handling of the above exception, another exception occurred:\n",
      "\u001b[1;31mAttributeError\u001b[0m                            Traceback (most recent call last)",
      "Cell \u001b[1;32mIn[12], line 2\u001b[0m\n\u001b[0;32m      1\u001b[0m loader \u001b[38;5;241m=\u001b[39m UnstructuredExcelLoader(file_path_1)\n\u001b[1;32m----> 2\u001b[0m docs \u001b[38;5;241m=\u001b[39m \u001b[43mloader\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mload\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m      3\u001b[0m splitted_documents \u001b[38;5;241m=\u001b[39m RecursiveCharacterTextSplitter(chunk_size \u001b[38;5;241m=\u001b[39m \u001b[38;5;241m1000\u001b[39m, chunk_overlap\u001b[38;5;241m=\u001b[39m\u001b[38;5;241m200\u001b[39m)\u001b[38;5;241m.\u001b[39msplit_documents(docs)\n",
      "File \u001b[1;32mh:\\Interview Preparation\\Coding\\GenAI\\Tryouts\\venv\\lib\\site-packages\\langchain_core\\document_loaders\\base.py:31\u001b[0m, in \u001b[0;36mBaseLoader.load\u001b[1;34m(self)\u001b[0m\n\u001b[0;32m     29\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21mload\u001b[39m(\u001b[38;5;28mself\u001b[39m) \u001b[38;5;241m-\u001b[39m\u001b[38;5;241m>\u001b[39m \u001b[38;5;28mlist\u001b[39m[Document]:\n\u001b[0;32m     30\u001b[0m \u001b[38;5;250m    \u001b[39m\u001b[38;5;124;03m\"\"\"Load data into Document objects.\"\"\"\u001b[39;00m\n\u001b[1;32m---> 31\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mlist\u001b[39;49m\u001b[43m(\u001b[49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mlazy_load\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[1;32mh:\\Interview Preparation\\Coding\\GenAI\\Tryouts\\venv\\lib\\site-packages\\langchain_community\\document_loaders\\unstructured.py:107\u001b[0m, in \u001b[0;36mUnstructuredBaseLoader.lazy_load\u001b[1;34m(self)\u001b[0m\n\u001b[0;32m    105\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21mlazy_load\u001b[39m(\u001b[38;5;28mself\u001b[39m) \u001b[38;5;241m-\u001b[39m\u001b[38;5;241m>\u001b[39m Iterator[Document]:\n\u001b[0;32m    106\u001b[0m \u001b[38;5;250m    \u001b[39m\u001b[38;5;124;03m\"\"\"Load file.\"\"\"\u001b[39;00m\n\u001b[1;32m--> 107\u001b[0m     elements \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_get_elements\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m    108\u001b[0m     \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_post_process_elements(elements)\n\u001b[0;32m    109\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mmode \u001b[38;5;241m==\u001b[39m \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124melements\u001b[39m\u001b[38;5;124m\"\u001b[39m:\n",
      "File \u001b[1;32mh:\\Interview Preparation\\Coding\\GenAI\\Tryouts\\venv\\lib\\site-packages\\langchain_community\\document_loaders\\excel.py:51\u001b[0m, in \u001b[0;36mUnstructuredExcelLoader._get_elements\u001b[1;34m(self)\u001b[0m\n\u001b[0;32m     48\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21m_get_elements\u001b[39m(\u001b[38;5;28mself\u001b[39m) \u001b[38;5;241m-\u001b[39m\u001b[38;5;241m>\u001b[39m List:\n\u001b[0;32m     49\u001b[0m     \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01munstructured\u001b[39;00m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mpartition\u001b[39;00m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mxlsx\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m partition_xlsx\n\u001b[1;32m---> 51\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m partition_xlsx(filename\u001b[38;5;241m=\u001b[39m\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mfile_path, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39m\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39munstructured_kwargs)\n",
      "File \u001b[1;32mh:\\Interview Preparation\\Coding\\GenAI\\Tryouts\\venv\\lib\\site-packages\\unstructured\\partition\\common\\metadata.py:184\u001b[0m, in \u001b[0;36mapply_metadata.<locals>.decorator.<locals>.wrapper\u001b[1;34m(*args, **kwargs)\u001b[0m\n\u001b[0;32m    182\u001b[0m languages \u001b[38;5;241m=\u001b[39m call_args\u001b[38;5;241m.\u001b[39mget(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mlanguages\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n\u001b[0;32m    183\u001b[0m detect_language_per_element \u001b[38;5;241m=\u001b[39m call_args\u001b[38;5;241m.\u001b[39mget(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mdetect_language_per_element\u001b[39m\u001b[38;5;124m\"\u001b[39m, \u001b[38;5;28;01mFalse\u001b[39;00m)\n\u001b[1;32m--> 184\u001b[0m elements \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mlist\u001b[39;49m\u001b[43m(\u001b[49m\n\u001b[0;32m    185\u001b[0m \u001b[43m    \u001b[49m\u001b[43mapply_lang_metadata\u001b[49m\u001b[43m(\u001b[49m\n\u001b[0;32m    186\u001b[0m \u001b[43m        \u001b[49m\u001b[43melements\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43melements\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    187\u001b[0m \u001b[43m        \u001b[49m\u001b[43mlanguages\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mlanguages\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    188\u001b[0m \u001b[43m        \u001b[49m\u001b[43mdetect_language_per_element\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mdetect_language_per_element\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    189\u001b[0m \u001b[43m    \u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m    190\u001b[0m \u001b[43m\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m    192\u001b[0m \u001b[38;5;66;03m# == apply filetype, filename, last_modified, and url metadata ===================\u001b[39;00m\n\u001b[0;32m    193\u001b[0m metadata_kwargs: \u001b[38;5;28mdict\u001b[39m[\u001b[38;5;28mstr\u001b[39m, Any] \u001b[38;5;241m=\u001b[39m {}\n",
      "File \u001b[1;32mh:\\Interview Preparation\\Coding\\GenAI\\Tryouts\\venv\\lib\\site-packages\\unstructured\\partition\\common\\lang.py:488\u001b[0m, in \u001b[0;36mapply_lang_metadata\u001b[1;34m(elements, languages, detect_language_per_element)\u001b[0m\n\u001b[0;32m    485\u001b[0m     elements \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mlist\u001b[39m(elements)\n\u001b[0;32m    487\u001b[0m full_text \u001b[38;5;241m=\u001b[39m \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m \u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;241m.\u001b[39mjoin(e\u001b[38;5;241m.\u001b[39mtext \u001b[38;5;28;01mfor\u001b[39;00m e \u001b[38;5;129;01min\u001b[39;00m elements \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28mhasattr\u001b[39m(e, \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mtext\u001b[39m\u001b[38;5;124m\"\u001b[39m))\n\u001b[1;32m--> 488\u001b[0m detected_languages \u001b[38;5;241m=\u001b[39m \u001b[43mdetect_languages\u001b[49m\u001b[43m(\u001b[49m\u001b[43mtext\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mfull_text\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mlanguages\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mlanguages\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m    489\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m (\n\u001b[0;32m    490\u001b[0m     detected_languages \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m\n\u001b[0;32m    491\u001b[0m     \u001b[38;5;129;01mand\u001b[39;00m \u001b[38;5;28mlen\u001b[39m(languages) \u001b[38;5;241m==\u001b[39m \u001b[38;5;241m1\u001b[39m\n\u001b[0;32m    492\u001b[0m     \u001b[38;5;129;01mand\u001b[39;00m detect_language_per_element \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;28;01mFalse\u001b[39;00m\n\u001b[0;32m    493\u001b[0m ):\n\u001b[0;32m    494\u001b[0m     \u001b[38;5;66;03m# -- apply detected language to each element's metadata --\u001b[39;00m\n\u001b[0;32m    495\u001b[0m     \u001b[38;5;28;01mfor\u001b[39;00m e \u001b[38;5;129;01min\u001b[39;00m elements:\n",
      "File \u001b[1;32mh:\\Interview Preparation\\Coding\\GenAI\\Tryouts\\venv\\lib\\site-packages\\unstructured\\partition\\common\\lang.py:447\u001b[0m, in \u001b[0;36mdetect_languages\u001b[1;34m(text, languages)\u001b[0m\n\u001b[0;32m    445\u001b[0m     langdetect_langs\u001b[38;5;241m.\u001b[39mappend(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mzho\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n\u001b[0;32m    446\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[1;32m--> 447\u001b[0m     language \u001b[38;5;241m=\u001b[39m \u001b[43m_get_iso639_language_object\u001b[49m\u001b[43m(\u001b[49m\u001b[43mlangobj\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mlang\u001b[49m\u001b[43m[\u001b[49m\u001b[43m:\u001b[49m\u001b[38;5;241;43m3\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m)\u001b[49m  \u001b[38;5;66;03m# pyright: ignore\u001b[39;00m\n\u001b[0;32m    448\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m language:\n\u001b[0;32m    449\u001b[0m         langdetect_langs\u001b[38;5;241m.\u001b[39mappend(language\u001b[38;5;241m.\u001b[39mpart3)\n",
      "File \u001b[1;32mh:\\Interview Preparation\\Coding\\GenAI\\Tryouts\\venv\\lib\\site-packages\\unstructured\\partition\\common\\lang.py:368\u001b[0m, in \u001b[0;36m_get_iso639_language_object\u001b[1;34m(lang)\u001b[0m\n\u001b[0;32m    366\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[0;32m    367\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m iso639\u001b[38;5;241m.\u001b[39mLanguage\u001b[38;5;241m.\u001b[39mmatch(lang\u001b[38;5;241m.\u001b[39mlower())  \u001b[38;5;66;03m# pyright: ignore[reportUnknownMemberType]\u001b[39;00m\n\u001b[1;32m--> 368\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m \u001b[43miso639\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mLanguageNotFoundError\u001b[49m:\n\u001b[0;32m    369\u001b[0m     logger\u001b[38;5;241m.\u001b[39mwarning(\u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;132;01m{\u001b[39;00mlang\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m is not a valid standard language code.\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n\u001b[0;32m    370\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m\n",
      "\u001b[1;31mAttributeError\u001b[0m: module 'iso639' has no attribute 'LanguageNotFoundError'"
     ]
    }
   ],
   "source": [
    "loader = UnstructuredExcelLoader(file_path_1)\n",
    "docs = loader.load()\n",
    "splitted_documents = RecursiveCharacterTextSplitter(chunk_size = 1000, chunk_overlap=200).split_documents(docs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content=\"event_type date_of_event product_problems complaint_txt follow_up manufacturer_narrative device_generic_name device_manufacturer_name device_model_number device_lot_number device_report_product_code expiration_date_of_device date_returned_to_manufacturer device_availability device_operator device_name Malfunction 20200418 ['Battery Problem', 'Power Problem'] INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS. (B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS\"),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='RETURNED FOR ANALYSIS. (B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY. ARTIFICIAL PANCREAS'),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content=\"TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY. ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND MEDTRONIC PUERTO RICO OPERATIONS CO. MMT-1715K HG1B44Y OZO 20200429 Device was returned to manufacturer LAY USER/PATIENT Automated Insulin Dosing , Threshold Suspend Malfunction 20200421 ['Excess Flow or Over-Infusion', 'Battery Problem', 'Adverse Event Without Identified Device or Use Problem', 'Appropriate Term/Code Not Available'] INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS. CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE\"),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content=\"FOR ANALYSIS. CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR MEDTRONIC MINIMED MMT-XXX OYC No LAY USER/PATIENT Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor Injury 20200407 ['Failure to Charge', 'Battery Problem'] FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF\"),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE) CD1357-40Q 4443992 LWS 20160131 20200422 Device was returned to manufacturer HEALTH'),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content=\"ADDITIONAL INFORMATION: D10, H7, H9 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE) CD1357-40Q 4443992 LWS 20160131 20200422 Device was returned to manufacturer HEALTH PROFESSIONAL Implantable Cardioverter Defibrillator (Non-Crt) Malfunction 20200402 ['Battery Problem'] IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT. NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. CONTINUOUS GLUCOSE MONITOR TANDEM DIABETES CARE 1000096 OYC No LAY USER/PATIENT Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor Malfunction 20200414 ['Battery Problem'] IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE\"),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content=\"Sensor Malfunction 20200414 ['Battery Problem'] IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT\"),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE'),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED.'),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE'),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH'),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content=\"FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. ICD BIOTRONIK SE & CO. KG 383594 LWS 20150228 20210302 Device was returned to manufacturer HEALTH PROFESSIONAL Implantable Cardioverter Defibrillator (Non-Crt) Malfunction 20200226 ['No Display/Image', 'Battery Problem', 'Device Markings/Labelling Problem',\"),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content=\"was returned to manufacturer HEALTH PROFESSIONAL Implantable Cardioverter Defibrillator (Non-Crt) Malfunction 20200226 ['No Display/Image', 'Battery Problem', 'Device Markings/Labelling Problem', 'Material Integrity Problem', 'Power Problem', 'Patient Device Interaction Problem'] INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE\"),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK'),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE'),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE'),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4). ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL MEDTRONIC PUERTO RICO OPERATIONS CO. MMT-1780KPK HG29Y7N OZP 20200309 Device was returned to manufacturer LAY'),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content=\"AND BECOME ILLEGIBLE. (B)(4). ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL MEDTRONIC PUERTO RICO OPERATIONS CO. MMT-1780KPK HG29Y7N OZP 20200309 Device was returned to manufacturer LAY USER/PATIENT Automated Insulin Dosing Device System, Single Hormonal Control Injury 20200422 ['Battery Problem'] FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A\"),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content=\"BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ABBOTT CD1233-40Q 3122369 LWS 20111130 20200505 Device was returned to manufacturer HEALTH PROFESSIONAL Implantable Cardioverter Defibrillator (Non-Crt) Injury 20200410 ['Battery Problem', 'Insufficient Information'] ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE. IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT\"),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content=\"INTERVENTION MAY BE PENDING. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. SCS IPG ST. JUDE MEDICAL - NEUROMODULATION 3662 5758833 LGW 20181213 No HEALTH PROFESSIONAL Stimulator, Spinal-Cord, Totally Implanted For Pain Relief Injury 20200331 ['Battery Problem'] INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED\"),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content=\"HEALTH PROFESSIONAL Stimulator, Spinal-Cord, Totally Implanted For Pain Relief Injury 20200331 ['Battery Problem'] INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED. ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. INTESTINAL STIMULATOR\"),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content=\"OF THIS EVENT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. INTESTINAL STIMULATOR MEDTRONIC PUERTO RICO OPERATIONS CO. 37800 LNQ 20181028 No HEALTH PROFESSIONAL Intestinal Stimulator Malfunction 20200427 ['Circuit Failure', 'Battery Problem', 'Material Integrity Problem'] INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS. (B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN\"),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS. (B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED'),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS'),\n",
       " Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP. PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR MEDTRONIC PUERTO RICO OPERATIONS CO. MMT-1711K HG1WT7E OYC 20200706 Device was returned to manufacturer LAY USER/PATIENT Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor')]"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "splitted_documents"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(25,\n",
       " [Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content=\"event_type date_of_event product_problems complaint_txt follow_up manufacturer_narrative device_generic_name device_manufacturer_name device_model_number device_lot_number device_report_product_code expiration_date_of_device date_returned_to_manufacturer device_availability device_operator device_name Malfunction 20200418 ['Battery Problem', 'Power Problem'] INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS. (B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS\"),\n",
       "  Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='RETURNED FOR ANALYSIS. (B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY. ARTIFICIAL PANCREAS'),\n",
       "  Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content=\"TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY. ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND MEDTRONIC PUERTO RICO OPERATIONS CO. MMT-1715K HG1B44Y OZO 20200429 Device was returned to manufacturer LAY USER/PATIENT Automated Insulin Dosing , Threshold Suspend Malfunction 20200421 ['Excess Flow or Over-Infusion', 'Battery Problem', 'Adverse Event Without Identified Device or Use Problem', 'Appropriate Term/Code Not Available'] INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS. CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE\"),\n",
       "  Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content=\"FOR ANALYSIS. CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR MEDTRONIC MINIMED MMT-XXX OYC No LAY USER/PATIENT Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor Injury 20200407 ['Failure to Charge', 'Battery Problem'] FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF\"),\n",
       "  Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE) CD1357-40Q 4443992 LWS 20160131 20200422 Device was returned to manufacturer HEALTH'),\n",
       "  Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content=\"ADDITIONAL INFORMATION: D10, H7, H9 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE) CD1357-40Q 4443992 LWS 20160131 20200422 Device was returned to manufacturer HEALTH PROFESSIONAL Implantable Cardioverter Defibrillator (Non-Crt) Malfunction 20200402 ['Battery Problem'] IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT. NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. CONTINUOUS GLUCOSE MONITOR TANDEM DIABETES CARE 1000096 OYC No LAY USER/PATIENT Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor Malfunction 20200414 ['Battery Problem'] IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE\"),\n",
       "  Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content=\"Sensor Malfunction 20200414 ['Battery Problem'] IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT\"),\n",
       "  Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE'),\n",
       "  Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED.'),\n",
       "  Document(metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE')])"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(splitted_documents), splitted_documents[:10]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### Creating vector DB from documents using embedding"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_community.vectorstores import FAISS\n",
    "from langchain_community.embeddings import OllamaEmbeddings, OpenAIEmbeddings, HuggingFaceEmbeddings"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\Admin\\AppData\\Local\\Temp\\ipykernel_16040\\2010306936.py:1: LangChainDeprecationWarning: The class `OllamaEmbeddings` was deprecated in LangChain 0.3.1 and will be removed in 1.0.0. An updated version of the class exists in the :class:`~langchain-ollama package and should be used instead. To use it run `pip install -U :class:`~langchain-ollama` and import as `from :class:`~langchain_ollama import OllamaEmbeddings``.\n",
      "  ollama_embedding = OllamaEmbeddings()\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<langchain_community.vectorstores.faiss.FAISS at 0x2a1e34ccf10>"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ollama_embedding = OllamaEmbeddings()\n",
    "vector_store_db = FAISS.from_documents(splitted_documents, ollama_embedding)\n",
    "vector_store_db"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "vector_store_db.save_local(\"Ollama_maude_vector_store\")\n",
    "#vector_store_db = FAISS.load_local(\"Ollama_maude_vector_store\", ollama_embeddings)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\Admin\\AppData\\Local\\Temp\\ipykernel_16040\\4140303849.py:1: LangChainDeprecationWarning: The class `OpenAIEmbeddings` was deprecated in LangChain 0.0.9 and will be removed in 1.0. An updated version of the class exists in the :class:`~langchain-openai package and should be used instead. To use it run `pip install -U :class:`~langchain-openai` and import as `from :class:`~langchain_openai import OpenAIEmbeddings``.\n",
      "  openAI_embedding = OpenAIEmbeddings()\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<langchain_community.vectorstores.faiss.FAISS at 0x2a1e3eff3d0>"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "openAI_embedding = OpenAIEmbeddings()\n",
    "openAI_vector_store_db = FAISS.from_documents(splitted_documents, openAI_embedding)\n",
    "openAI_vector_store_db"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [],
   "source": [
    "openAI_vector_store_db.save_local(\"OpenAI_maude_vector_store\")\n",
    "#openAI_vector_store_db = FAISS.load_local(\"OpenAI_maude_vector_store\", openAI_embedding)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### Query Vector Store"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(id='aed004eb-a490-4f7b-930a-c03836359e50', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content=\"FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. ICD BIOTRONIK SE & CO. KG 383594 LWS 20150228 20210302 Device was returned to manufacturer HEALTH PROFESSIONAL Implantable Cardioverter Defibrillator (Non-Crt) Malfunction 20200226 ['No Display/Image', 'Battery Problem', 'Device Markings/Labelling Problem',\"),\n",
       " Document(id='7d3a5e79-9402-44a7-8cd9-6f652ef3cedb', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content=\"HEALTH PROFESSIONAL Stimulator, Spinal-Cord, Totally Implanted For Pain Relief Injury 20200331 ['Battery Problem'] INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED. ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. INTESTINAL STIMULATOR\"),\n",
       " Document(id='fe7ea586-8524-4272-b2f9-182d1974113b', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP. PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR MEDTRONIC PUERTO RICO OPERATIONS CO. MMT-1711K HG1WT7E OYC 20200706 Device was returned to manufacturer LAY USER/PATIENT Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor'),\n",
       " Document(id='a0813494-d5e7-4565-a421-b75905a950f7', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='RETURNED FOR ANALYSIS. (B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY. ARTIFICIAL PANCREAS')]"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "query=\"What are the potential hazards present in the data?\"\n",
    "docs=vector_store_db.similarity_search(query)\n",
    "docs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(id='a5af9501-85f9-4eef-9945-d1eae08b1e00', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK'),\n",
       " Document(id='215b1db7-1c95-42f2-bf79-854f99bb06c7', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH'),\n",
       " Document(id='2df65cf0-f202-4317-9f48-8e08d0f522cc', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE'),\n",
       " Document(id='62297153-0c72-499c-bbb6-5535c0e4d0fd', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS')]"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "query=\"What are the potential hazards present in the data?\"\n",
    "openai_docs=openAI_vector_store_db.similarity_search(query)\n",
    "openai_docs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[(Document(id='aed004eb-a490-4f7b-930a-c03836359e50', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content=\"FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. ICD BIOTRONIK SE & CO. KG 383594 LWS 20150228 20210302 Device was returned to manufacturer HEALTH PROFESSIONAL Implantable Cardioverter Defibrillator (Non-Crt) Malfunction 20200226 ['No Display/Image', 'Battery Problem', 'Device Markings/Labelling Problem',\"),\n",
       "  18848.082),\n",
       " (Document(id='7d3a5e79-9402-44a7-8cd9-6f652ef3cedb', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content=\"HEALTH PROFESSIONAL Stimulator, Spinal-Cord, Totally Implanted For Pain Relief Injury 20200331 ['Battery Problem'] INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED. ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. INTESTINAL STIMULATOR\"),\n",
       "  18910.621),\n",
       " (Document(id='fe7ea586-8524-4272-b2f9-182d1974113b', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP. PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR MEDTRONIC PUERTO RICO OPERATIONS CO. MMT-1711K HG1WT7E OYC 20200706 Device was returned to manufacturer LAY USER/PATIENT Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor'),\n",
       "  19340.734),\n",
       " (Document(id='a0813494-d5e7-4565-a421-b75905a950f7', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='RETURNED FOR ANALYSIS. (B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY. ARTIFICIAL PANCREAS'),\n",
       "  19899.428)]"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "docs_and_score=vector_store_db.similarity_search_with_score(query)\n",
    "docs_and_score"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[(Document(id='a5af9501-85f9-4eef-9945-d1eae08b1e00', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK'),\n",
       "  0.48276165),\n",
       " (Document(id='215b1db7-1c95-42f2-bf79-854f99bb06c7', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH'),\n",
       "  0.4829978),\n",
       " (Document(id='2df65cf0-f202-4317-9f48-8e08d0f522cc', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE'),\n",
       "  0.4921661),\n",
       " (Document(id='62297153-0c72-499c-bbb6-5535c0e4d0fd', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS'),\n",
       "  0.49284127)]"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "openai_docs_and_score=openAI_vector_store_db.similarity_search_with_score(query)\n",
    "openai_docs_and_score"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### Creating retrievers & query "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(id='b2117a69-5686-46ca-b16a-22b568e52d70', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content=\"HEALTH PROFESSIONAL Stimulator, Spinal-Cord, Totally Implanted For Pain Relief Injury 20200331 ['Battery Problem'] INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED. ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. INTESTINAL STIMULATOR\"),\n",
       " Document(id='9974f528-b950-41e0-99e1-2deb0bff579d', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content=\"FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. ICD BIOTRONIK SE & CO. KG 383594 LWS 20150228 20210302 Device was returned to manufacturer HEALTH PROFESSIONAL Implantable Cardioverter Defibrillator (Non-Crt) Malfunction 20200226 ['No Display/Image', 'Battery Problem', 'Device Markings/Labelling Problem',\"),\n",
       " Document(id='df6777c4-160e-4149-9f87-f018d0c95cc6', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP. PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR MEDTRONIC PUERTO RICO OPERATIONS CO. MMT-1711K HG1WT7E OYC 20200706 Device was returned to manufacturer LAY USER/PATIENT Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor'),\n",
       " Document(id='b4de1202-8b56-4ead-90ac-a456413d3fa4', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='RETURNED FOR ANALYSIS. (B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY. ARTIFICIAL PANCREAS')]"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "retriever=vector_store_db.as_retriever()\n",
    "retr_docs=retriever.invoke(query)\n",
    "retr_docs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(id='a5af9501-85f9-4eef-9945-d1eae08b1e00', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK'),\n",
       " Document(id='215b1db7-1c95-42f2-bf79-854f99bb06c7', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH'),\n",
       " Document(id='2df65cf0-f202-4317-9f48-8e08d0f522cc', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE'),\n",
       " Document(id='62297153-0c72-499c-bbb6-5535c0e4d0fd', metadata={'source': 'fda_device_data - Subset.xlsx', 'filename': 'fda_device_data - Subset.xlsx', 'last_modified': '2025-01-15T13:22:44', 'page_name': 'FDA Data', 'page_number': 1, 'text_as_html': '<table><tr><td>event_type</td><td>date_of_event</td><td>product_problems</td><td>complaint_txt</td><td>follow_up</td><td>manufacturer_narrative</td><td>device_generic_name</td><td>device_manufacturer_name</td><td>device_model_number</td><td>device_lot_number</td><td>device_report_product_code</td><td>expiration_date_of_device</td><td>date_returned_to_manufacturer</td><td>device_availability</td><td>device_operator</td><td>device_name</td></tr><tr><td>Malfunction</td><td>20200418</td><td>[\\'Battery Problem\\', \\'Power Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP ALARMED WITH ALARM GENERATED WHEN A POWER SYSTEM ERROR WAS DETECTED AND THIS ERROR DOES NOT PREVENT THE PUMP FROM RUNNING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER ALSO REPORTED EXPERIENCING POWER ERROR FOR 3 DAYS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR POWER ERROR ALARM. CUSTOMER WAS ADVISED TO REVERT TO THE BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. DEVICE PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, SELF TEST AND DISPLACEMENT TEST. HOWEVER, DEVICE TRACE DOWNLOAD ANALYSIS CONFIRMED THE INSULIN PUMP ALARMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT AND REPLACE BATTERY NOW ALARM. THE ADAPT TOOL CONFIRMED POWER ERROR 25, POWER LOSS ALARM, REPLACE BATTERY ALERT, REPLACE BATTERY NOW ALARM WAS TRIGGERED WHEN THE BACKUP BATTERY LOADED VOLTAGE (LOADED VLITH) WAS LESS THAN 3.5V FOR 4 CONSECUTIVE HOURS DUE TO CONNECTOR RESISTANCE ELECTRICAL BOARD. AFTER DISCONNECTING AND RECONNECTING THE INTERNAL BATTERY CONNECTOR ON ELECTRICAL BOARD, DEVICE WAS MONITORED AND FUNCTIONED PROPERLY.</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1715K</td><td>HG1B44Y</td><td>OZO</td><td/><td>20200429</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing , Threshold Suspend</td></tr><tr><td>Malfunction</td><td>20200421</td><td>[\\'Excess Flow or Over-Infusion\\', \\'Battery Problem\\', \\'Adverse Event Without Identified Device or Use Problem\\', \\'Appropriate Term/Code Not Available\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP AND RESERVOIR HAD OVER DELIVERY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. TROUBLESHOOT WAS NOT PERFORMED. THE INSULIN PUMP AND RESERVOIR WILL NOT BE RETURNING FOR ANALYSIS.</td><td/><td>CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC MINIMED</td><td>MMT-XXX</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Injury</td><td>20200407</td><td>[\\'Failure to Charge\\', \\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN. THE DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS FOUND TO BE AT ELECTIVE REPLACEMENT INDICATOR (ERI) AND CAPACITOR EXCEEDED THE CHARGED TIME. THE PATIENT WAS RECOVERING.</td><td/><td>THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON 28 AUGUST 2017. THE REPORTED EVENT OF CHARGE TIME OUT WAS CONFIRMED. THE CAUSE OF CHARGE TIME OUT WAS DUE TO PREMATURE BATTERY DEPLETION. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LI CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016. ADDITIONAL INFORMATION: D10, H7, H9</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ST. JUDE MEDICAL, INC.(CRM-SUNNYVALE)</td><td>CD1357-40Q</td><td>4443992</td><td>LWS</td><td>20160131</td><td>20200422</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200402</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THE PUMP BATTERY WAS DEPLETING QUICKLY. THERE WAS NO REPORTED IMPACT TO THE CUSTOMERÂ¿S BLOOD GLUCOSE LEVEL. THE CUSTOMER DECLINED TO PERFORM TROUBLESHOOTING AND DECLINED FOLLOW UP FROM TANDEM TECHNICAL SUPPORT.</td><td/><td>NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.</td><td>CONTINUOUS GLUCOSE MONITOR</td><td>TANDEM DIABETES CARE</td><td>1000096</td><td/><td>OYC</td><td/><td/><td>No</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr><tr><td>Malfunction</td><td>20200414</td><td>[\\'Battery Problem\\']</td><td>IT WAS REPORTED THAT THIS DEVICE TRIPPED ERI ON (B)(6) 2020. THE DATA ANALYSIS PERFORMED BY THE MANUFACTURER INDICATED A BATTERY ISSUE. NO ADVERSE PATIENT EVENTS WERE REPORTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS FILE WILL BE UPDATED.</td><td/><td>THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. PRIOR TO THE ANALYSIS OF THE DEVICE, THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS ICD WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE DEVICE INTERROGATION REVEALED THE EOS BATTERY STATUS, DETECTED AFTER EXPLANTATION OF THE DEVICE ON (B)(6) 2020. THE DEVICE WAS IMPLANTED FOR APPROXIMATELY 73 MONTHS AND 31 CHARGING CYCLES WERE RECORDED IN THE DEVICES MEMORY. THE ICD WAS SUBJECTED TO AN ELECTRICAL ANALYSIS. THE CURRENT CONSUMPTION OF THE ICD WAS FOUND TO BE NORMAL AND AS EXPECTED. HOWEVER, AN INCONSISTENCY BETWEEN THE AMOUNT OF CHARGE TAKEN FROM THE BATTERY AND THE BATTERY VOLTAGE WAS NOTED. IN ORDER TO OBTAIN FURTHER INSIGHTS, THE ICD WAS OPENED AND THE INNER ASSEMBLY WAS INSPECTED. THE VISUAL INSPECTION SHOWED NO ANOMALIES. SUBSEQUENTLY THE CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS VERIFIED BY DIRECT MEASUREMENT AND PROVED TO BE AS EXPECTED AND CONSISTENT WITH THE INTERROGATED ICD DATA. THERE WAS NO INDICATION OF A MALFUNCTION OF THE ELECTRONIC MODULE. THEREFORE, THE BATTERY WAS DISCONNECTED FROM THE ELECTRONIC MODULE AND SENT TO THE MANUFACTURER FOR FURTHER ANALYSIS. DURING ANALYSIS OF THE BATTERY LITHIUM PLATING WAS IDENTIFIED, WHICH LED TO AN ELEVATED INTERNAL SELF-DEPLETION AND, AS A RESULT, TO THE CLINICAL OBSERVATION. PLEASE NOTE, THIS ICD IS AFFECTED BY THE FIELD SAFETY CORRECTIVE ACTION, BIO-LQC, INITIATED IN MARCH 2021. IT WAS REPORTED THAT THIS DEVICE WAS EXPLANTED ON (B)(6) 2020. THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE ONLY BASED ON THE RETURNED DEVICE DATA AS WELL AS THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING. IN A NEXT STEP, THE RETURNED DEVICE DATA WAS INSPECTED. DURING THE INSPECTION THE CLINICAL OBSERVATION COULD BE CONFIRMED. FURTHER ANALYSIS REVEALED AN UNEXPECTED BATTERY BEHAVIOR, WHICH LED TO THE CLINICAL OBSERVATION. BASED ON THE DATA AVAILABLE FOR ANALYSIS THE ROOT CAUSE FOR THAT BEHAVIOR WAS NOT DETERMINABLE AND CAN ONLY BE CLARIFIED BY AN ANALYSIS OF THE DEVICE ITSELF. HOWEVER, IT CANNOT BE EXCLUDED THAT THIS OCCURRENCE RESULTED FROM A DAMAGED COMPONENT, WHICH MAY COMPROMISE THE ABILITY OF THE DEVICE TO DELIVER THERAPY. THEREFORE AND IN ORDER TO EXCLUDE ANY POTENTIAL HARM FOR THE PATIENT WE WOULD LIKE TO RECOMMEND TO REPLACE THE DEVICE AND TO RETURN IT FOR ANALYSIS TO BIOTRONIK. OF COURSE, INDIVIDUAL CIRCUMSTANCES AND MEDICAL JUDGMENT DETERMINE DECISIONS ABOUT PATIENT CARE AND THE FREQUENCY OF FOLLOW-UP SESSIONS. THE ABOVE RECOMMENDATION IS BASED ON A PURELY TECHNICAL ASSESSMENT. SHOULD FURTHER RELEVANT INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.</td><td>ICD</td><td>BIOTRONIK SE &amp; CO. KG</td><td>383594</td><td/><td>LWS</td><td>20150228</td><td>20210302</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Malfunction</td><td>20200226</td><td>[\\'No Display/Image\\', \\'Battery Problem\\', \\'Device Markings/Labelling Problem\\', \\'Material Integrity Problem\\', \\'Power Problem\\', \\'Patient Device Interaction Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD LOW BATTERY AND BLANK DISPLAY. THE CUSTOMER STATED WAS UNABLE TO GET THE INSULIN PUMP TURN ON ALSO CUSTOMER HAD THE BATTERY CAP CONTACT MISSING AND THE SN LABEL WORN OFF. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.</td><td/><td>UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. THIS REPORT IS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION EFFORTS IN RESPONSE TO A WARNING LETTER. UPDATED H9: Z-0956-2020 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. UNIT PASSED SLEEP CURRENT MEASUREMENT, ACTIVE CURRENT MEASUREMENT, AND SELF TESTS. NO UNEXPECTED BLANK DISPLAYS OR UNEXPECTED Â¿LOW BATTERYÂ¿, Â¿REPLACE BATTERY NOWÂ¿, OR \"POWER LOSS\" ERRORS WERE NOTED DURING TESTING. UNIT RECEIVED WITH A PARTIALLY BROKEN OFF PIECE AT THE RESERVOIR TUBE LIP, A MISSING RETAINER RING, AND A MISSING RESERVOIR TUBE LIP O-RING. UNABLE TO PERFORM THE DISPLACEMENT TEST SINCE P-CAP / RESERVOIR WILL NOT LOCK PROPERLY DUE TO THE MISSING RETAINER. IN ADDITION TO THIS, THE S/N LABEL LOCATED BETWEEN THE BELT CLIP RAILS HAS RUBBED OFF AND BECOME ILLEGIBLE. (B)(4).</td><td>ARTIFICIAL PANCREAS DEVICE SYSTEM, SINGLE HORMONAL CONTROL</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1780KPK</td><td>HG29Y7N</td><td>OZP</td><td/><td>20200309</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Automated Insulin Dosing Device System, Single Hormonal Control</td></tr><tr><td>Injury</td><td>20200422</td><td>[\\'Battery Problem\\']</td><td>FOLLOWING THE BATTERY PERFORMANCE ALERT (BPA) ADVISORY, A BPA WAS RECEIVED BY THE CLINICIAN AND THE DEVICE WAS EXPLANTED. THE PATIENT WAS IN STABLE CONDITION.</td><td/><td>THE DEVICE IS INCLUDED IN THE BATTERY PERFORMANCE ALERT ADVISORY ISSUED BY ABBOTT ON (B)(6) 2017. THE RESULTS, METHOD, AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. PREMATURE BATTERY DEPLETION WAS CONFIRMED BY ANALYSIS. NO SOURCES OF HIGH CURRENT WERE NOTED. THE CAUSE OF THE PREMATURE BATTERY DEPLETION WAS CONSISTENT WITH LITHIUM (LI) CLUSTER FORMATION. FROM THESE ANALYSES, IN THE ABSENCE OF HIGH CURRENT DRAW, IT IS PROBABLE THAT THE PREMATURE BATTERY DEPLETION WAS CAUSED BY A LITHIUM CLUSTER INDUCED SHORT CIRCUIT. LI CLUSTERS ARE A KNOWN DEPLETION MECHANISM FOR THESE ADVISORY PRODUCTS THAT HAS BEEN INVESTIGATED AND ASSOCIATED WITH A FIELD ACTION IN OCTOBER 2016.</td><td>IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td><td>ABBOTT</td><td>CD1233-40Q</td><td>3122369</td><td>LWS</td><td>20111130</td><td>20200505</td><td>Device was returned to manufacturer</td><td>HEALTH PROFESSIONAL</td><td>Implantable Cardioverter Defibrillator (Non-Crt)</td></tr><tr><td>Injury</td><td>20200410</td><td>[\\'Battery Problem\\', \\'Insufficient Information\\']</td><td>ADDITIONAL INFORMATION INDICATES THE IPG WAS EXPLANTED AND REPLACED TO ADDRESS THE ISSUE.</td><td>IT WAS REPORTED THE IPG HAS REACHED END OF SERVICE. IN TURN, SURGICAL INTERVENTION MAY BE PENDING.</td><td>THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN THE FINAL REPORT. DATE OF EVENT IS ESTIMATED. DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE PATIENT INFORMATION. FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.</td><td>SCS IPG</td><td>ST. JUDE MEDICAL - NEUROMODULATION</td><td>3662</td><td>5758833</td><td>LGW</td><td>20181213</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Stimulator, Spinal-Cord, Totally Implanted For Pain Relief</td></tr><tr><td>Injury</td><td>20200331</td><td>[\\'Battery Problem\\']</td><td>INFORMATION WAS RECEIVED FROM A CONSUMER (CON) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT THOUGHT THEIR INS WAS DEAD BECAUSE THEY HAD A LOT OF PAIN IN THEIR LOWER BACK. THEY STATED THEY WERE IN THE HOSPITAL WITH PAIN. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.</td><td>ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THEY PROVIDED THEIR WEIGHT AT THE TIME OF THE EVENT. THEY STATED THERE WERE NO CIRCUMSTANCES LEADING TO THE DEAD INS AND PAIN. THEY WERE DOING NOTHING WHEN THE PAIN STARTED. IT WAS NOT RESOLVED AT THE TIME OF THE REPORT. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.</td><td>IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.</td><td>INTESTINAL STIMULATOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>37800</td><td/><td>LNQ</td><td>20181028</td><td/><td>No</td><td>HEALTH PROFESSIONAL</td><td>Intestinal Stimulator</td></tr><tr><td>Malfunction</td><td>20200427</td><td>[\\'Circuit Failure\\', \\'Battery Problem\\', \\'Material Integrity Problem\\']</td><td>INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP HAD MULTIPLE PUMP ERROR ALARMS. CUSTOMER WAS ABLE TO SUCCESSFULLY CLEAR THE ALARM AND ABLE TO REWIND THE INSULIN PUMP. CUSTOMER REPORTED THAT BATTERY CAP METAL CONNECTOR WAS ALSO LOOSE. CUSTOMER ALSO REPORTED THAT TROUBLESHOOT WAS PERFORMED FOR PUMP ERROR ALARM. CUSTOMER WAS PERFORMING SELF TEST AND IT DID NOT PASS. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.</td><td/><td>(B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THE INSULIN PUMP INVOLVED IN THIS EVENT IS THE 640G INSULIN INFUSION PUMP, WHICH IS NOT MARKETED IN THE UNITED STATES. HOWEVER, THE DEVICE IS SIMILAR TO THE PARADIGM REAL-TIME INSULIN INFUSION PUMP, WHICH IS MARKETED IN THE UNITED STATES. UPDATED H9: 2032227-060322-002-C MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. DEVICE PASSED THE DISPLACEMENT TEST. HOWEVER, PUMP ERROR 63 ALARM (VARIABLE INFO=3) DURING SELF TEST AND CONFIRMED IN THE DEVICE HISTORY DUE COLD SOLDER JOINT ON U1 KEYPAD ASSEMBLY. NO ERROR 25 ALARM NOTED IN THE HISTORY FILE. UNABLE TO CONFIRM BATTERY CAP DAMAGE DUE TO INSULIN PUMP RECEIVED WITHOUT THE ORIGINAL BATTERY CAP.</td><td>PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR</td><td>MEDTRONIC PUERTO RICO OPERATIONS CO.</td><td>MMT-1711K</td><td>HG1WT7E</td><td>OYC</td><td/><td>20200706</td><td>Device was returned to manufacturer</td><td>LAY USER/PATIENT</td><td>Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor</td></tr></table>', 'languages': ['eng'], 'filetype': 'application/vnd.openxmlformats-officedocument.spreadsheetml.sheet', 'category': 'Table', 'element_id': '320ca8fab18750d93b6fea81eb973f5c'}, page_content='NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY \"DEFECTS\" OR HAS \"MALFUNCTIONED\". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS')]"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "openai_retriever=openAI_vector_store_db.as_retriever()\n",
    "openai_retr_docs=openai_retriever.invoke(query)\n",
    "openai_retr_docs"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Document Chain & Context Passing"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Creating Agentic RAG"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.11"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
